Literature DB >> 14576053

Endothelial progenitor cells in infantile hemangioma.

Ying Yu1, Alan F Flint, John B Mulliken, June K Wu, Joyce Bischoff.   

Abstract

Infantile hemangioma is an endothelial tumor that grows rapidly after birth but slowly regresses during early childhood. Initial proliferation of hemangioma is characterized by clonal expansion of endothelial cells (ECs) and neovascularization. Here, we demonstrated mRNA encoding CD133-2, an important marker for endothelial progenitor cells (EPCs), predominantly in proliferating but not involuting or involuted hemangioma. Progenitor cells coexpressing CD133 and CD34 were detected by flow cytometry in 11 of 12 proliferating hemangioma specimens from children 3 to 24 months of age. Furthermore, in 4 proliferating hemangiomas, we showed that 0.14% to 1.6% of CD45(-) nucleated cells were EPCs that coexpressed CD133 and the EC marker KDR. This finding is consistent with the presence of KDR(+) immature ECs in proliferating hemangioma. Our results suggest that EPCs contribute to the early growth of hemangioma. To our knowledge, this is the first study to show direct evidence of EPCs in a human vascular tumor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576053     DOI: 10.1182/blood-2003-08-2859

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  53 in total

Review 1.  Infantile hemangioma-mechanism(s) of drug action on a vascular tumor.

Authors:  Shoshana Greenberger; Joyce Bischoff
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

Review 2.  Pathogenesis of vascular anomalies.

Authors:  Laurence M Boon; Fanny Ballieux; Miikka Vikkula
Journal:  Clin Plast Surg       Date:  2011-01       Impact factor: 2.017

Review 3.  Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment.

Authors:  Chelsey J Forbess Smith; Sheila Fallon Friedlander; Monica Guma; Arthur Kavanaugh; Christina D Chambers
Journal:  Birth Defects Res       Date:  2017-04-12       Impact factor: 2.344

4.  Myeloid cells in infantile hemangioma.

Authors:  Matthew R Ritter; John Reinisch; Sheila Fallon Friedlander; Martin Friedlander
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

5.  Evidence by molecular profiling for a placental origin of infantile hemangioma.

Authors:  Carmen M Barnés; Sui Huang; Arja Kaipainen; Despina Sanoudou; Emy J Chen; Gabriel S Eichler; Yuchun Guo; Ying Yu; Donald E Ingber; John B Mulliken; Alan H Beggs; Judah Folkman; Steven J Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 6.  Common Pediatric Skin Lesions: A Comprehensive Review of the Current Literature.

Authors:  Faryan Jalalabadi; Jeffrey G Trost; Joshua A Cox; Edward I Lee; Crystal Y Pourciau
Journal:  Semin Plast Surg       Date:  2016-08       Impact factor: 2.314

7.  Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapy.

Authors:  C J Kleber; A Spiess; J B Kleber; U Hinz; S Holland-Cunz; J Weiss
Journal:  Eur J Pediatr       Date:  2011-12-28       Impact factor: 3.183

8.  Treatment of hemangioma by transfection of antisense VEGF gene.

Authors:  Shengguo Shan; Guang Shan; Duanlian Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

9.  E-selectin mediates stem cell adhesion and formation of blood vessels in a murine model of infantile hemangioma.

Authors:  David M Smadja; John B Mulliken; Joyce Bischoff
Journal:  Am J Pathol       Date:  2012-10-04       Impact factor: 4.307

10.  PDGFR-β (+) perivascular cells from infantile hemangioma display the features of mesenchymal stem cells and show stronger adipogenic potential in vitro and in vivo.

Authors:  Si-Ming Yuan; Yao Guo; Xiao-Jun Zhou; Wei-Min Shen; Hai-Ni Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.